Table 4 |
||
|
Manifestation |
Clinical Features |
Examples of causative drugs |
|
|
||
|
Skin Exanthemata |
• Diffuse, fine macules and papules • Evolve over days post drug initiation |
Allopurinol, penicillins, cephalosporins, anticonvulsants, sulfonamides |
|
|
||
|
Urticaria, angioedema |
• Onset within minutes to hours of drug administration • Potential for anaphylaxis • Often IgE-mediated |
Antibiotics, ACE inhibitors, anticonvulsants, neuromuscular blocking agents, platinums, radiocontrast media, NSAIDs, narcotics |
|
|
||
|
Fixed drug eruption |
• Hyper-pigmented plaques that occur at the same site upon re-exposure to the culprit drug |
Sulfonamide and tetracycline antibiotics, NSAIDs, ASA, sedatives, chemotherapeutic agents, anticonvulsants |
|
|
||
|
SJS |
• Fever, sore throat, fatigue, ocular involvement • Ulcers and other lesions on mucous membranes, particularly of the mouth and lips, as well as on truncal area |
Sulfonamides, nevirapine, corticosteroids, anticonvulsants, NSAIDs (oxicams), allopurinol, phenytoin, carbamazepine, lamotrigine, barbiturates, psychotropic agents, pantoprazole, tramadol |
|
|
||
|
TEN |
• Similar to SJS, but usually involves significant epidermal detachment • Potentially life-threatening |
Same as SJS |
|
|
||
|
Hematologic |
• Hemolytic anemia, leukopenia, thrombocytopenia |
Penicillin, sulfonamides, anticonvulsants, cephalosporins, quinine, heparin, thiazides, gold salts |
|
|
||
|
Hepatic |
• Hepatitis, cholestatic jaundice |
Sulfonamides, phenothiazines, carbamazepine, erythromycin, anti-tuberculosis agents, allopurinol, gold |
|
|
||
|
Renal |
• Interstitial nephritis, glomerulonephritis |
Penicillin, sulfonamides, allopurinol, PPIs, ACE inhibitors, NSAIDs |
|
|
||
|
Multi-organ reactions Anaphylaxis |
• Urticaria/angioedema, bronchospasm, gastrointestinal symptoms, hypotension |
Antibiotics, neuromuscular blocking agents, anesthetics, radiocontrast media, recombinant proteins (e.g., omalizumab) |
|
|
||
|
DRESS |
• Cutaneous eruption, fever, eosinophilia, hepatic dysfunction, lymphadenopathy |
Anticonvulsants, sulfonamides, minocycline, allopurinol, strontium ranelate |
|
|
||
|
Serum sickness |
• Urticaria, arthralgias, fever |
Heterologous antibodies, infliximab, allopurinol, thiazides, antibiotics (e.g., cefaclor) and bupropion |
|
|
||
|
DILE |
• Arthralgias, myalgias, fever, malaise |
Hydralazine, procainamide, isoniazid, quinidine, minocycline, antibiotics, and anti–TNF-alpha agents |
|
|
||
|
Vasculitis |
• Cutaneous or visceral vasculitis |
Sulfonamide antibiotics and diuretics, hydralazine, penicillamine, propylthiouracil |
|
|
||
|
ACE: angiotensin-converting enzyme; NSAIDs: non-steroid anti-inflammatory drugs; SJS: Stevens-Johnson syndrome; TEN: toxic epidermal necrolysis; DRESS: Drug rash with eosinophilia and systemic symptoms; DILE: drug-induced lupus erythematosus; ASA: acetylsalicylic acid; PPIs: proton pump inhibitors; TNF: tumour necrosis factor |
||
|
Warrington and Silviu-Dan Allergy, Asthma & Clinical Immunology 2011 7(Suppl 1):S10 doi:10.1186/1710-1492-7-S1-S10 |
||